カテゴリ： 世界, 医療/バイオ, QYResearch

不活化ポリオワクチンの世界市場2023年：タイプⅠ、タイプⅡ、タイプⅢ

■ 英語タイトル：Global Inactivated Polio Virus Vaccine Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8795）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8795
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：69
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[不活化ポリオワクチンの世界市場2023年：タイプⅠ、タイプⅡ、タイプⅢ]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は不活化ポリオワクチンのグローバル市場について調査・分析し、世界の不活化ポリオワクチン市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（タイプⅠ、タイプⅡ、タイプⅢ）、用途別セグメント分析（病院、診療所）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Sanofi、GSK、Serum Institute (Bilthoven Biologicals)、IMBCAなどが含まれています。不活化ポリオワクチンのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、不活化ポリオワクチン市場規模を算出する際に考慮しました。

・不活化ポリオワクチン市場の概要
- 不活化ポリオワクチンの種類別セグメント
- 世界の不活化ポリオワクチン市場規模：タイプ別分析（タイプⅠ、タイプⅡ、タイプⅢ）
- 不活化ポリオワクチンの用途別セグメント
- 世界の不活化ポリオワクチン市場規模：用途別分析（病院、診療所）
- 世界の不活化ポリオワクチン市場規模予測（2018年-2029年）

・不活化ポリオワクチン市場の成長トレンド
- 不活化ポリオワクチンの地域別市場規模（2018年-2029年）
- 不活化ポリオワクチン市場ダイナミクス
- 不活化ポリオワクチンの業界動向
- 不活化ポリオワクチン市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：タイプⅠ、タイプⅡ、タイプⅢ
- 世界の不活化ポリオワクチンのタイプ別市場規模（2018年-2023年）
- 世界の不活化ポリオワクチンのタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、診療所
- 世界の不活化ポリオワクチンの用途別市場規模（2018年-2023年）
- 世界の不活化ポリオワクチンの用途別市場規模（2024年-2029年）

・不活化ポリオワクチンの地域別市場規模
- 北米の不活化ポリオワクチン市場規模（2018年-2029年）
- 米国の不活化ポリオワクチン市場規模（2018年-2029年）
- ヨーロッパの不活化ポリオワクチン市場規模（2018年-2029年）
- アジア太平洋の不活化ポリオワクチン市場規模（2018年-2029年）
- 中国の不活化ポリオワクチン市場規模（2018年-2029年）
- 日本の不活化ポリオワクチン市場規模（2018年-2029年）
- 韓国の不活化ポリオワクチン市場規模（2018年-2029年）
- インドの不活化ポリオワクチン市場規模（2018年-2029年）
- オーストラリアの不活化ポリオワクチン市場規模（2018年-2029年）
- 中南米の不活化ポリオワクチン市場規模（2018年-2029年）
- 中東・アフリカの不活化ポリオワクチン市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Sanofi、GSK、Serum Institute (Bilthoven Biologicals)、IMBCA

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Inactivated Polio Virus Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Inactivated Polio Virus Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Inactivated Polio Virus Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Inactivated Polio Virus Vaccine in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Inactivated Polio Virus Vaccine include Sanofi, GSK, Serum Institute (Bilthoven Biologicals) and IMBCA, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inactivated Polio Virus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Polio Virus Vaccine.
The Inactivated Polio Virus Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Inactivated Polio Virus Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Polio Virus Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Segment by Type
Type I
Type II
Type III
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inactivated Polio Virus Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inactivated Polio Virus Vaccine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Market by Application
1.3.1 Global Inactivated Polio Virus Vaccine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inactivated Polio Virus Vaccine Market Perspective (2018-2029)
2.2 Inactivated Polio Virus Vaccine Growth Trends by Region
2.2.1 Global Inactivated Polio Virus Vaccine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Inactivated Polio Virus Vaccine Historic Market Size by Region (2018-2023)
2.2.3 Inactivated Polio Virus Vaccine Forecasted Market Size by Region (2024-2029)
2.3 Inactivated Polio Virus Vaccine Market Dynamics
2.3.1 Inactivated Polio Virus Vaccine Industry Trends
2.3.2 Inactivated Polio Virus Vaccine Market Drivers
2.3.3 Inactivated Polio Virus Vaccine Market Challenges
2.3.4 Inactivated Polio Virus Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inactivated Polio Virus Vaccine Players by Revenue
3.1.1 Global Top Inactivated Polio Virus Vaccine Players by Revenue (2018-2023)
3.1.2 Global Inactivated Polio Virus Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Inactivated Polio Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Inactivated Polio Virus Vaccine Revenue
3.4 Global Inactivated Polio Virus Vaccine Market Concentration Ratio
3.4.1 Global Inactivated Polio Virus Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inactivated Polio Virus Vaccine Revenue in 2022
3.5 Inactivated Polio Virus Vaccine Key Players Head office and Area Served
3.6 Key Players Inactivated Polio Virus Vaccine Product Solution and Service
3.7 Date of Enter into Inactivated Polio Virus Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inactivated Polio Virus Vaccine Breakdown Data by Type
4.1 Global Inactivated Polio Virus Vaccine Historic Market Size by Type (2018-2023)
4.2 Global Inactivated Polio Virus Vaccine Forecasted Market Size by Type (2024-2029)
5 Inactivated Polio Virus Vaccine Breakdown Data by Application
5.1 Global Inactivated Polio Virus Vaccine Historic Market Size by Application (2018-2023)
5.2 Global Inactivated Polio Virus Vaccine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Inactivated Polio Virus Vaccine Market Size (2018-2029)
6.2 North America Inactivated Polio Virus Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Inactivated Polio Virus Vaccine Market Size by Country (2018-2023)
6.4 North America Inactivated Polio Virus Vaccine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inactivated Polio Virus Vaccine Market Size (2018-2029)
7.2 Europe Inactivated Polio Virus Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Inactivated Polio Virus Vaccine Market Size by Country (2018-2023)
7.4 Europe Inactivated Polio Virus Vaccine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inactivated Polio Virus Vaccine Market Size (2018-2029)
8.2 Asia-Pacific Inactivated Polio Virus Vaccine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Region (2018-2023)
8.4 Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inactivated Polio Virus Vaccine Market Size (2018-2029)
9.2 Latin America Inactivated Polio Virus Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Inactivated Polio Virus Vaccine Market Size by Country (2018-2023)
9.4 Latin America Inactivated Polio Virus Vaccine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inactivated Polio Virus Vaccine Market Size (2018-2029)
10.2 Middle East & Africa Inactivated Polio Virus Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2018-2023)
10.4 Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Inactivated Polio Virus Vaccine Introduction
11.1.4 Sanofi Revenue in Inactivated Polio Virus Vaccine Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Inactivated Polio Virus Vaccine Introduction
11.2.4 GSK Revenue in Inactivated Polio Virus Vaccine Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Serum Institute (Bilthoven Biologicals)
11.3.1 Serum Institute (Bilthoven Biologicals) Company Detail
11.3.2 Serum Institute (Bilthoven Biologicals) Business Overview
11.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Introduction
11.3.4 Serum Institute (Bilthoven Biologicals) Revenue in Inactivated Polio Virus Vaccine Business (2018-2023)
11.3.5 Serum Institute (Bilthoven Biologicals) Recent Development
11.4 IMBCA
11.4.1 IMBCA Company Detail
11.4.2 IMBCA Business Overview
11.4.3 IMBCA Inactivated Polio Virus Vaccine Introduction
11.4.4 IMBCA Revenue in Inactivated Polio Virus Vaccine Business (2018-2023)
11.4.5 IMBCA Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Inactivated Polio Virus Vaccine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Type I
Table 3. Key Players of Type II
Table 4. Key Players of Type III
Table 5. Global Inactivated Polio Virus Vaccine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Inactivated Polio Virus Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Inactivated Polio Virus Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Inactivated Polio Virus Vaccine Market Share by Region (2018-2023)
Table 9. Global Inactivated Polio Virus Vaccine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Inactivated Polio Virus Vaccine Market Share by Region (2024-2029)
Table 11. Inactivated Polio Virus Vaccine Market Trends
Table 12. Inactivated Polio Virus Vaccine Market Drivers
Table 13. Inactivated Polio Virus Vaccine Market Challenges
Table 14. Inactivated Polio Virus Vaccine Market Restraints
Table 15. Global Inactivated Polio Virus Vaccine Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Inactivated Polio Virus Vaccine Market Share by Players (2018-2023)
Table 17. Global Top Inactivated Polio Virus Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Virus Vaccine as of 2022)
Table 18. Ranking of Global Top Inactivated Polio Virus Vaccine Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Inactivated Polio Virus Vaccine Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Inactivated Polio Virus Vaccine Product Solution and Service
Table 22. Date of Enter into Inactivated Polio Virus Vaccine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Inactivated Polio Virus Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Inactivated Polio Virus Vaccine Revenue Market Share by Type (2018-2023)
Table 26. Global Inactivated Polio Virus Vaccine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Inactivated Polio Virus Vaccine Revenue Market Share by Type (2024-2029)
Table 28. Global Inactivated Polio Virus Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Inactivated Polio Virus Vaccine Revenue Market Share by Application (2018-2023)
Table 30. Global Inactivated Polio Virus Vaccine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Inactivated Polio Virus Vaccine Revenue Market Share by Application (2024-2029)
Table 32. North America Inactivated Polio Virus Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Inactivated Polio Virus Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Inactivated Polio Virus Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Inactivated Polio Virus Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Inactivated Polio Virus Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Inactivated Polio Virus Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Inactivated Polio Virus Vaccine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Inactivated Polio Virus Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Inactivated Polio Virus Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Inactivated Polio Virus Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 47. Sanofi Company Detail
Table 48. Sanofi Business Overview
Table 49. Sanofi Inactivated Polio Virus Vaccine Product
Table 50. Sanofi Revenue in Inactivated Polio Virus Vaccine Business (2018-2023) & (US$ Million)
Table 51. Sanofi Recent Development
Table 52. GSK Company Detail
Table 53. GSK Business Overview
Table 54. GSK Inactivated Polio Virus Vaccine Product
Table 55. GSK Revenue in Inactivated Polio Virus Vaccine Business (2018-2023) & (US$ Million)
Table 56. GSK Recent Development
Table 57. Serum Institute (Bilthoven Biologicals) Company Detail
Table 58. Serum Institute (Bilthoven Biologicals) Business Overview
Table 59. Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Product
Table 60. Serum Institute (Bilthoven Biologicals) Revenue in Inactivated Polio Virus Vaccine Business (2018-2023) & (US$ Million)
Table 61. Serum Institute (Bilthoven Biologicals) Recent Development
Table 62. IMBCA Company Detail
Table 63. IMBCA Business Overview
Table 64. IMBCA Inactivated Polio Virus Vaccine Product
Table 65. IMBCA Revenue in Inactivated Polio Virus Vaccine Business (2018-2023) & (US$ Million)
Table 66. IMBCA Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inactivated Polio Virus Vaccine Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Inactivated Polio Virus Vaccine Market Share by Type: 2022 VS 2029
Figure 3. Type I Features
Figure 4. Type II Features
Figure 5. Type III Features
Figure 6. Global Inactivated Polio Virus Vaccine Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Inactivated Polio Virus Vaccine Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Inactivated Polio Virus Vaccine Report Years Considered
Figure 11. Global Inactivated Polio Virus Vaccine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Inactivated Polio Virus Vaccine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Inactivated Polio Virus Vaccine Market Share by Region: 2022 VS 2029
Figure 14. Global Inactivated Polio Virus Vaccine Market Share by Players in 2022
Figure 15. Global Top Inactivated Polio Virus Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Virus Vaccine as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Inactivated Polio Virus Vaccine Revenue in 2022
Figure 17. North America Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Inactivated Polio Virus Vaccine Market Share by Country (2018-2029)
Figure 19. United States Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Inactivated Polio Virus Vaccine Market Share by Country (2018-2029)
Figure 23. Germany Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Inactivated Polio Virus Vaccine Market Share by Region (2018-2029)
Figure 31. China Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Inactivated Polio Virus Vaccine Market Share by Country (2018-2029)
Figure 39. Mexico Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Inactivated Polio Virus Vaccine Market Share by Country (2018-2029)
Figure 43. Turkey Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Inactivated Polio Virus Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Sanofi Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2018-2023)
Figure 46. GSK Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2018-2023)
Figure 47. Serum Institute (Bilthoven Biologicals) Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2018-2023)
Figure 48. IMBCA Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2018-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 食品用コート紙の世界市場2023年：タイプI、タイプIII、タイプII
  • P-アミノアセトアニリド（4-アミノアセトアニリド）のグローバル市場展望 2023年-2029年：タイプI、タイプII
  • 高安全リチウムイオン電池のグローバル市場展望 2023年-2029年：特殊リチウム電池、タイプII
  • 世界の不活化ポリオワクチン市場2022年：市場規模予測（～2028年）
  • 世界の不活化ポリオ＆狂犬病ワクチン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8795 )"不活化ポリオワクチンの世界市場2023年：タイプⅠ、タイプⅡ、タイプⅢ" (英文：Global Inactivated Polio Virus Vaccine Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。